LIN9 regulation of NEK2 underlies taxol resistance in triple-negative breast cancer

被引：0
|
作者：
Shively, Melyssa S. [1 ]
Keri, Ruth A. [1 ]
机构：
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-2097
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2097
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
    Shu, Shaokun
    Lin, Charles Y.
    He, Housheng Hansen
    Witwicki, Robert M.
    Tabassum, Doris P.
    Roberts, Justin M.
    Janiszewska, Michalina
    Huh, Sung Jin
    Liang, Yi
    Ryan, Jeremy
    Doherty, Ernest
    Mohammed, Hisham
    Guo, Hao
    Stover, Daniel G.
    Ekram, Muhammad B.
    Peluffo, Guillermo
    Brown, Jonathan
    D'Santos, Clive
    Krop, Ian E.
    Dillon, Deborah
    McKeown, Michael
    Ott, Christopher
    Qi, Jun
    Ni, Min
    Rao, Prakash K.
    Duarte, Melissa
    Wu, Shwu-Yuan
    Chiang, Cheng-Ming
    Anders, Lars
    Young, Richard A.
    Winer, Eric P.
    Letai, Antony
    Barry, William T.
    Carroll, Jason S.
    Long, Henry W.
    Brown, Myles
    Liu, X. Shirley
    Meyer, Clifford A.
    Bradner, James E.
    Polyak, Kornelia
    NATURE, 2016, 529 (7586) : 413 - +
  • [42] Talazoparib nanoparticles for overcoming multidrug resistance in triple-negative breast cancer
    Eskiler, Gamze Guney
    Cecener, Gulsah
    Egeli, Unal
    Tunca, Berrin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (09) : 6230 - 6245
  • [43] Proteomic analysis of talazoparib resistance in triple-negative breast cancer cells
    Guney Eskiler, Gamze
    Yanar, Sevinc
    Akpinar, Gurler
    Kasap, Murat
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2021, 35 (03)
  • [44] Overcoming Chemotherapy Resistance: A Nanomedicine Approach to Triple-Negative Breast Cancer
    Liu, Xueying
    Kinoh, Hiroaki
    Quader, Sabina
    Cabral, Horacio
    Kataoka, Kazunori
    CANCER SCIENCE, 2025, 116 : 1234 - 1234
  • [45] CRIF1-CDK2 Interface Inhibitors Enhance Taxol Inhibition of the Lethal Triple-Negative Breast Cancer
    Sang, Xiaoye
    Belmessabih, Nassira
    Wang, Ruixuan
    Stephen, Preyesh
    Lin, Sheng-Xiang
    CANCERS, 2022, 14 (04)
  • [46] Nek2-targeted ASO or siRNA pretreatment enhances anticancer drug sensitivity in triple-negative breast cancer cells
    Lee, Jaehyung
    Gollahon, Lauren
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 42 (03) : 839 - 847
  • [47] Schlafen Family Intra-Regulation by IFN-α2 in Triple-Negative Breast Cancer
    Brown, Savannah R.
    Vomhof-DeKrey, Emilie E.
    Al-Marsoummi, Sarmad
    Brown, Nicholas D.
    Hermanson, Kole
    Basson, Marc D.
    CANCERS, 2023, 15 (23)
  • [48] BRCA2 Mutations and Triple-Negative Breast Cancer
    Meyer, Peter
    Landgraf, Katharina
    Hoegel, Bernhard
    Eiermann, Wolfgang
    Ataseven, Beyhan
    PLOS ONE, 2012, 7 (05):
  • [49] Discovery of Potent and Selective CDK9 Degraders for Targeting Transcription Regulation in Triple-Negative Breast Cancer
    Wei, Dan
    Wang, Hanlin
    Zeng, Qinghe
    Wang, Wenjing
    Hao, Bingbing
    Feng, Xule
    Wang, Peipei
    Song, Ning
    Kan, Weijuan
    Huang, Guifang
    Zhou, Xiaoyu
    Tan, Minjia
    Zhou, Yubo
    Huang, Ruimin
    Li, Jia
    Chen, Xiao-Hua
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (19) : 14822 - 14847
  • [50] Epigenetic Dysregulation of KCNK9 Imprinting and Triple-Negative Breast Cancer
    Skaar, David A.
    Dietze, Eric C.
    Alva-Ornelas, Jackelyn A.
    Ann, David
    Schones, Dustin E.
    Hyslop, Terry
    Sistrunk, Christopher
    Zalles, Carola
    Ambrose, Adrian
    Kennedy, Kendall
    Idassi, Ombeni
    Miranda Carboni, Gustavo
    Gould, Michael N.
    Jirtle, Randy L.
    Seewaldt, Victoria L.
    CANCERS, 2021, 13 (23)
12345